Antihypertensive  treatment – navigating between cost, compliance and complications

David Conen

doi:10.4414/smw.2013.13857

Viewpoint

Vol. 143 No. 4344 (2013)

Antihypertensive treatment – navigating between cost, compliance and complications

David Conen

DOI: https://doi.org/10.4414/smw.2013.13857
Cite this as:: Swiss Med Wkly. 2013;143:w13857
Published: 20.10.2013

References

Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217–23.
Conen D, Ridker PM, Buring JE, Glynn RJ. Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study. BMJ. 2007;335:432.
Conen D, Tedrow UB, Koplan BA, Glynn RJ, Buring JE, Albert CM. Influence of Systolic and Diastolic Blood Pressure on the Risk of Incident Atrial Fibrillation in Women. Circulation. 2009;119:2146–52.
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–13.
Turnbull F. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet. 2003;362:1527–35.
Schäfer H, Schenuert U. Costs of current antihypertensive therapy in Switzerland: an economic evaluation of 3,489 patients in primary care. Swiss Med Wkly. 2013;143:w13854 http://www.smw.ch/content/smw-2013-13854/.
Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients. Am J Med. 2012;125:882–7 e1.

How to Cite

1.

Conen D. Antihypertensive treatment – navigating between cost, compliance and complications. Swiss Med Wkly [Internet]. 2013 Oct. 20 [cited 2024 Nov. 19];143(4344):w13857. Available from: https://smw.ch/index.php/smw/article/view/1764

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Most read articles by the same author(s)

Annina Stauber, Andreas Müller, Nikki Rommers, Stefanie Aeschbacher, Nicolas Rodondi, Leo H. Bonati, Juerg H. Beer, Raban V. Jeger, David J. Kurz, Claudia Liedtke, Peter Ammann, Marcello Di Valentino, Patricia Chocano, Richard Kobza, Michael Kühne, David Conen, Stefan Osswald, Alain M. Bernheim, Association of chocolate consumption with neurological and cardiovascular outcomes in atrial fibrillation: data from two Swiss atrial fibrillation cohort studies (Swiss-AF and BEAT-AF) , Swiss Medical Weekly: Vol. 153 No. 8 (2023)
David Conen, Nicolas Rodondi, Andreas Müller, Juerg H. Beer, Angelo Auricchio, Peter Ammann, Daniel Hayoz, Richard Kobza, Giorgio Moschovitis, Dipen Shah, Jürg Schläpfer, Jan Novak, Marcello Di Valentino, Paul Erne, Christian Sticherling, Leo H. Bonati, Georg Ehret, Laurent Roten, Urs Fischer, Andreas Monsch, Christoph Stippich, Jens Wuerfel, Matthias Schwenkglenks, Michael Kühne, Stefan Osswald, for the Swiss-AF study investigators, Design of the Swiss Atrial Fibrillation Cohort Study (Swiss-AF): structural brain damage and cognitive decline among patients with atrial fibrillation , Swiss Medical Weekly: Vol. 147 No. 2728 (2017)
Michael Ke Wang, Rachel Heo, Pascal B. Meyre, Steffen Blum, Louis Park, Lauren Birchenough, Kiven Vuong, William F. McIntyre, Jeff S. Healey, Philip J. Devereaux, Michael McMullen, Marko Mrkobrada, Natalia Pinilla-Echeverri, Kim Styles, David Conen, Anticoagulation use in perioperative atrial fibrillation after noncardiac surgery: a systematic review and meta-analysis , Swiss Medical Weekly: Vol. 153 No. 4 (2023)
Valentina Forni Ogna, Adam Ogna, Belen Ponte, Luca Gabutti, Isabelle Binet, David Conen, Paul Erne, Augusto Gallino, Idris Guessous, Daniel Hayoz, Franco Muggli, Fred Paccaud, Antoinette Péchère-Bertchi, Paolo M. Suter, Murielle Bochud, Michel Burnier, Prevalence and determinants of chronic kidney disease in the Swiss population , Swiss Medical Weekly: Vol. 146 No. 1718 (2016)
Nicolas Glatz, Aline Chappuis, David Conen, Paul Erne, Antoinette Péchère-Bertschi, Idris Guessous, Valentina Forni, Luca Gabutti, Franco Muggli, Augusto Gallino, Daniel Hayoz, Isabelle Binet, Paolo Suter, Fred Paccaud, Murielle Bochud, Michel Burnier, Swiss Medical Weekly, Associations of sodium, potassium and protein intake with blood pressure and hypertension in Switzerland , Swiss Medical Weekly: Vol. 147 No. 0708 (2017)
Pascal Meyre, David Conen, Stefan Osswald, Michael Kühne, Christine S. Zuern, Atrial fibrillation for internists: current practice , Swiss Medical Weekly: Vol. 150 No. 1112 (2020)
Matylda Zimny, Steffen Blum, Peter Ammann, Paul Erne, Giorgio Moschovitis, Marcello Di Valentino, Dipen Shah, Jürg Schläpfer, Cyrill Vogt, Alexandra Tabord, Michael Kühne, Christian Sticherling, Stefan Osswald, David Conen, Uptake of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation – a prospective cohort study , Swiss Medical Weekly: Vol. 147 No. 0506 (2017)
Francisco J. Ruperti Repilado, Laura Doerig, Steffen Blum, Stefanie Aeschbacher, Philipp Krisai, Peter Ammann, Paul Erne, Giorgio Moschovitis, Marcello di Valentino, Dipen Shah, Jürg Schläpfer, Samuel Stempfel, Michael Kühne, Christian Sticherling, Stefan Osswald, David Conen, Prevalence and predictors of atrial fibrillation type among individuals with recent onset of atrial fibrillation , Swiss Medical Weekly: Vol. 148 No. 3738 (2018)
Stefanie Aeschbacher, Tobias Schoen, Carole Clair, Paula Schillinger, Selina Schönenberger, Martin Risch, Lorenz Risch, David Conen, Association of smoking and nicotine dependence with pre-diabetes in young and healthy adults , Swiss Medical Weekly: Vol. 144 No. 4142 (2014)
David Conen, Tobias Schön, Stefanie Aeschbacher, Guillaume Paré, Walter Frehner, Martin Risch, Lorenz Risch, Genetic and phenotypic determinants of blood pressure and other cardiovascular risk factors , Swiss Medical Weekly: Vol. 143 No. 0102 (2013)

1 2 > >>

[1] Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217–23.

[2] Conen D, Ridker PM, Buring JE, Glynn RJ. Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study. BMJ. 2007;335:432.

[3] Conen D, Tedrow UB, Koplan BA, Glynn RJ, Buring JE, Albert CM. Influence of Systolic and Diastolic Blood Pressure on the Risk of Incident Atrial Fibrillation in Women. Circulation. 2009;119:2146–52.

[4] Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–13.

[5] Turnbull F. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet. 2003;362:1527–35.

[6] Schäfer H, Schenuert U. Costs of current antihypertensive therapy in Switzerland: an economic evaluation of 3,489 patients in primary care. Swiss Med Wkly. 2013;143:w13854 http://www.smw.ch/content/smw-2013-13854/.

[7] Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients. Am J Med. 2012;125:882–7 e1.